Search Results - "Lemons, Richard S."

Refine Results
  1. 1
  2. 2

    Mapping the Evidence for Opioid-Mediated Changes in Malignancy and Chemotherapeutic Efficacy: Protocol for a Scoping Review by Constance, Jonathan E, McFarland, Mary M, Casucci, Tallie, Deininger, Michael W, Enioutina, Elena Y, Job, Kathleen, Lemons, Richard S, Lim, Carol S, Ward, Robert M, Yellepeddi, Venkata, Watt, Kevin M

    Published in JMIR research protocols (22-05-2023)
    “…Numerous reports contend opioids can augment or inhibit malignancy. At present, there is no consensus on the risk or benefit posed by opioids on malignancy or…”
    Get full text
    Journal Article
  3. 3

    Neonatal hemolytic jaundice: morphologic features of erythrocytes that will help you diagnose the underlying condition by Christensen, Robert D, Yaish, Hassan M, Lemons, Richard S

    Published in Neonatology (Basel, Switzerland) (01-01-2014)
    “…Many cases of severe neonatal hyperbilirubinemia never have the underlying cause of the jaundice clearly identified. Thus they are said to have 'idiopathic'…”
    Get more information
    Journal Article
  4. 4

    Neonatal nonimmune hemolytic anemia by Yaish, Hassan M, Christensen, Robert D, Lemons, Richard S

    Published in Current opinion in pediatrics (01-02-2017)
    “…As in adults and older children, anemia in newborn infants can be the result of erythropoietic failure, hemorrhage, or hemolysis. When hemolysis is the prime…”
    Get full text
    Journal Article
  5. 5

    Supportive care medications coinciding with chemotherapy among children with hematologic malignancy by Biltaji, Eman, Enioutina, Elena Y., Yellepeddi, Venkata, Rower, Joseph E., Sherwin, Catherine M. T., Ward, Robert M., Lemons, Richard S., Constance, Jonathan E.

    Published in Leukemia & lymphoma (02-07-2020)
    “…Pharmacokinetic (PK) conflicts can arise between supportive care medications (SCM) and chemotherapy in children with hematologic malignancy (HM). In this…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Dronabinol Prescribing and Exposure Among Children and Young Adults Diagnosed with Cancer by Rower, Joseph E, King, Amber D, Wilkins, Diana, Wilkes, Jacob, Yellepeddi, Venkata, Maese, Luke, Lemons, Richard S, Constance, Jonathan E

    “…The therapeutic utility of in cancer is a topic of intense interest. Dronabinol is synthetic Δ -tetrahydrocannabinol (THC), the primary psychoactive component…”
    Get more information
    Journal Article
  8. 8

    Oral Step-Down Therapy With Levofloxacin for Febrile Neutropenia in Children With Cancer by Olson, Jared, Mehra, Sonia, Hersh, Adam L, Thorell, Emily A, Stoddard, Gregory J, Maese, Luke, Barnette, Phillip E, Lemons, Richard S, Pavia, Andrew T, Knackstedt, Elizabeth D

    “…Abstract Background Although febrile neutropenia (FN) is a frequent complication in children with cancer receiving chemotherapy, there remains significant…”
    Get full text
    Journal Article
  9. 9

    Safety, dose, and timing of Reteplase in treating occluded central venous catheters in children with cancer by TERRILL, Kelly R, LEMONS, Richard S, GOLDSBY, Robert E

    Published in Journal of pediatric hematology/oncology (01-11-2003)
    “…Recombinant tissue plasminogen activator, alteplase, began to be commonly used to restore the patency of occluded central venous catheters (CVCs) as urokinase…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Treatment-related costs of pediatric acute lymphoblastic leukemia by Kaul, Sapna, Lemons, Richard S., Korgenski, Kent, Ng, Christi, Nelson, Richard, Raetz, Elizabeth A., Fluchel, Mark, Kirchhoff, Anne C.

    Published in Journal of clinical oncology (20-10-2014)
    “…Abstract only 23 Background: Few studies have examined costs of pediatric cancer care and we lack a clear understanding of cost trends. In this study, we…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    Retinoid therapy of childhood cancer by Reynolds, C P, Lemons, R S

    “…In vitro studies that showed RA could cause growth arrest and differentiation of myelogenous leukemia and neuroblastoma led to clinical trials of retinoids in…”
    Get more information
    Journal Article
  18. 18

    Molecular analysis of human complement component C5: localization of the structural gene to chromosome 9 by Wetsel, Rick A, Lemons, Richard S, Le Beau, Michelle M, Barnum, Scott R, Noack, Deborah, Tack, Brian F

    Published in Biochemistry (Easton) (08-03-1988)
    “…A human C5 clone (pC5HG2) was isolated from a cDNA library constructed from Hep G2 mRNA. The DNA sequence showed that the pC5HG2 insert was comprised of 3309…”
    Get full text
    Journal Article
  19. 19

    Translocation and Rearrangement of Myeloperoxidase Gene in Acute Promyelocytic Leukemia by Weil, Susan C., Rosner, Gayle L., Reid, Martha S., Chisholm, Rex L., Lemons, Richard S., Swanson, Maurice S., Carrino, John J., Diaz, Manuel O., Le Beau, Michelle M.

    “…Acute promyelocytic leukemia (subtype M3) is characterized by malignant promyelocytes exhibiting an abundance of abnormally large or aberrant primary granules…”
    Get full text
    Journal Article
  20. 20

    A Tumor Suppressor-Dependent Inhibitor of Angiogenesis is Immunologically and Functionally Indistinguishable from a Fragment of Thrombospondin by Good, Deborah J., Polverini, Peter J., Rastinejad, Farzan, Le Beau, Michelle M., Lemons, Richard S., Frazier, William A., Bouck, Noel P.

    “…A secreted inhibitor of angiogenesis that is controlled by a tumor suppressor gene in hamster cells has been found to be similar to a fragment of the platelet…”
    Get full text
    Journal Article